Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 61

Sort by

Sort Order Select

Journal Articles

Double Blind Randomized Control Trial of Postoperative Low Molecular Weight Heparin Bridging Therapy for Patients Who Are at High Risk for Arterial Thromboembolism (PERIOP 2)

Michael J. Kovacs, MD, Marc Rodger, MDMSc, Philip S. Wells, MDMSc,FRCP, Shannon M. Bates, MD MSc, Clive Kearon, MB, PhD, Mark Blostein, MDFRCPC, Alejandro Lazo-Langner, MD MSc, Susan Kahn, MD, Sam Schulman, MD PhD FRCPC, Elham Sabri, MSc, Susan Solymoss, MD, Timothy Ramsay, PhD, Luljeta Pallaveshi, RN, BA, David Anderson, MD

Blood (2018) 132 (Supplement 1): 424.

https://doi.org/10.1182/blood-2018-99-109964

Published: 2018

Journal Articles

Long-Term Risk Factors for Occult Cancer Detection in Patients with Unprovoked Venous Thromboembolism: A Post-Hoc Analysis of the Reverse Study

Nathan Cantor, BSc., Marc Carrier, MD MSc, Marc A. Rodger, MD MSc, Gabrielle Veillet-Lemay, Elham Sabri, MSc, Michael J. Kovacs, MD

Blood (2018) 132 (Supplement 1): 1230.

https://doi.org/10.1182/blood-2018-99-113023

Published: 2018

Journal Articles

A Randomized, Open-Label, Blinded Outcome Assessment Trial Evaluating the Efficacy and Safety of LMWH/Edoxaban Versus Dalteparin for Venous Thromboembolism Associated with Cancer: Hokusai VTE-Cancer Study

Gary E. Raskob, PhD, Nick Van Es, MD, Peter Verhamme, MD PhD, Marc Carrier, MD, Marcello Di Nisio, MD, David A. Garcia, MD, Michael A. Grosso, MD, Ajay K. Kakkar, MBBS, Michael J. Kovacs, MD, Michele F. Mercuri, MD PhD FAHA, Guy Meyer, MD, Annelise Segers, MD, Minggao Shi, PhD, Tzu-Fei Wang, MD, Erik Yeo, MD FACP, FRCPC, George Zhang, PhD, Jeffrey I. Zwicker, MD, Jeffrey I. Weitz, MD, Harry R. Büller, MD PhD

Blood (2017) 130 (Supplement 1): LBA-6.

https://doi.org/10.1182/blood.V130.Suppl_1.LBA-6.LBA-6

Published: 2017

Journal Articles

Post-Thrombotic Syndrome and Functional Disability in Patients with Upper Extremity Deep Vein Thrombosis: A Prospective Cohort Study

Alejandro Lazo-Langner, MD MSc, FRCPC, Susan R Kahn, MD MSc, Philip S Wells, MD, David Anderson, MD, Marc Rodger, MD MSc, Marc Carrier, MD MSc, FRCPC, Annmarie A. Bosco, MBBS, BSc (MD, Judy Kovacs, RN, Roweena Corpuz, RN, Michael J. Kovacs, MD FRCPC

Blood (2016) 128 (22): 417.

https://doi.org/10.1182/blood.V128.22.417.417

Published: 2016

Journal Articles

Do Genetic Contributors to Warfarin Responsiveness or Common Thrombophilias Influence the Risk of Major Bleeding in Patients on Extended Duration Vitamin K Antagonist (VKA) for Venous Thromboembolic Disease?

Philip S Wells, MD, Michael J. Kovacs, MD FRCPC, David Anderson, MD, Susan R. Kahn, MD, Clive Kearon, MB, Sam Schulman, MD PhD FRCPC, David M. Keeling, MD, Scott Kaatz, DO, MSc, Susan Solymoss, MD, Daniel J Corsi, PhD, Marc Rodger, MD MSc, FRCPC

Blood (2016) 128 (22): 272.

https://doi.org/10.1182/blood.V128.22.272.272

Published: 2016

Journal Articles

Long Term Monitoring of Patients with Positive Lupus Anticoagulant and Antiphospholipid Antibodies. Are All Cases Persistently Positive?

Matthew R. Kovacs, Alejandro Lazo-Langner, MD MSc, FRCPC, Martha L Louzada, MD, Michael J. Kovacs, MD FRCPC

Blood (2016) 128 (22): 1452.

https://doi.org/10.1182/blood.V128.22.1452.1452

Published: 2016

Journal Articles

Prediction of Bleeding Risk in Patients on Extended Oral Anticoagulation for Venous Thromboembolism

Blood (2016) 128 (22): 139.

https://doi.org/10.1182/blood.V128.22.139.139

Published: 2016

Journal Articles

Lupus Anticoagulant Testing in Patients Receiving Rivaroxaban or Apixaban for the Treatment of Venous Thromboembolism

Matthew R. Kovacs, Alejandro Lazo-Langner, MD MSc, FRCPC, Martha L Louzada, MD, Michael J. Kovacs, MD FRCPC

Blood (2016) 128 (22): 5017.

https://doi.org/10.1182/blood.V128.22.5017.5017

Published: 2016

Journal Articles

A Pilot Study in Cancer Patients with Central Venous Catheter Associated Deep Vein Thrombosis in Upper Extremity Treated with Rivaroxaban (Catheter 2)

Gwynivere A Davies, MD FRCPC, Alejandro Lazo-Langner, MD MSc, FRCPC, Esteban Gandara, MD MSc, FRCPC, Vicky Tagalakis, MD MSc, Martha L Louzada, MD, Roweena Corpuz, RN, Michael J. Kovacs, MD FRCPC

Blood (2016) 128 (22): 878.

https://doi.org/10.1182/blood.V128.22.878.878

Published: 2016

Journal Articles

Safety of Weight-Adjusted Dosing of LMWH in Clinically Obese Cancer Patients with Venous Thromboembolism

Gillian Mount, MD MSc, Michael J. Kovacs, MD FRCPC, Alejandro Lazo-Langner, MD MSc, FRCPC, Lenicio Siqueira, BSc, Martha L Louzada, MD

Blood (2016) 128 (22): 882.

https://doi.org/10.1182/blood.V128.22.882.882

Published: 2016

Journal Articles

Evaluating the Need for Anticoagulation Beyond 6 Months for Patients with Cancer-Associated Venous Thromboembolism (VTE): A Retrospect of Real Life (EXTEND study - updated results)

Martha L Louzada, BSc, MD MSc, Fatimah Al-Ani, MD MRCP, Michael J. Kovacs, MD, Lenicio Siqueira, BSc, Alejandro Lazo-Langner, MD MSc

Blood (2015) 126 (23): 2320.

https://doi.org/10.1182/blood.V126.23.2320.2320

Published: 2015

Journal Articles

Management of T-Cell Large Granular Lymphocyte Leukemia with Methotrexate or Cyclophosphamide

Matthew R. Kovacs, Cyrus C. Hsia, MDBSc,FRCPC, Alejandro Lazo-Langner, MD MSc, Michael J. Kovacs, MD FRCPC

Blood (2015) 126 (23): 5290.

https://doi.org/10.1182/blood.V126.23.5290.5290

Published: 2015

Journal Articles

Updates on the Risk of Dalteparin Thromboprophylaxis Failure in Hospitalized Acutely Ill Medical Patients with Cancer (ARTIC STUDY)

Martha L Louzada, BSc, MD MSc, Fatimah Al-Ani, MD MRCP, Michael J. Kovacs, MD FRCPC, Lenicio Siqueira, BSc, Alejandro Lazo-Langner, MD MSc

Blood (2015) 126 (23): 1116.

https://doi.org/10.1182/blood.V126.23.1116.1116

Published: 2015

Journal Articles

Brain Natriuretic Peptide, Troponin and D-Dimer Levels in Relation to Long-Term Functional Outcome after a First Episode of Pulmonary Embolism: Results from the E.L.O.P.E. Study

Susan R Kahn, MD MSc, Andrew Hirsch, MD, Margaret Beddaoui, MSc, Arash Akaberi, MSc, David Anderson, MD, Philip S Wells, MDMSc, Marc Rodger, MD MSc, Susan Solymoss, MD, Michael J. Kovacs, MD, Lawrence Rudski, MD, Avi Shimony, MD, Carole Dennie, MD, Chris Rush, MD, William H. Geerts, MD, Paul Hernandez, MD, Shawn Aaron, MD, John T Granton, MD

Blood (2015) 126 (23): 649.

https://doi.org/10.1182/blood.V126.23.649.649

Published: 2015

Journal Articles

"Post-Pulmonary Embolism Syndrome" after a First Episode of PE: Results of the E.L.O.P.E. Study

Blood (2015) 126 (23): 650.

https://doi.org/10.1182/blood.V126.23.650.650

Published: 2015

Journal Articles

A Prospective Cohort Study of Upper Extremity Deep Vein Thrombosis

Alejandro Lazo-Langner, MD MSc, Susan R Kahn, MD MSc, Philip S Wells, MDMSc, David Anderson, MD, Marc Rodger, MD MSc, Marc Carrier, MD MSc, Annmarie A. Bosco, MBBS, BSc (MD, Judy Kovacs, RN, Roweena Corpuz, RN, Michael J. Kovacs, MD FRCPC

Blood (2015) 126 (23): 893.

https://doi.org/10.1182/blood.V126.23.893.893

Published: 2015

Journal Articles

Dyspnea, Quality of Life and Walking Capacity during 1 Year Follow-up after a First Episode of Pulmonary Embolism: Results of the E.L.O.P.E. Study

Blood (2015) 126 (23): 750.

https://doi.org/10.1182/blood.V126.23.750.750

Published: 2015

Journal Articles

Evaluating the Need for Anticoagulation Beyond 6 Months for Patients with Cancer-Associated Venous Thromboembolism: A Retrospect of Real Life (EXTEND Study)

Martha L Louzada, BSc, MD MSc, Michael J. Kovacs, MD FRCPC, Fatimah Al-ani, MD, Lenicio Siqueira, Alejandro Lazo-Langner, MD MSc

Blood (2014) 124 (21): 4245.

https://doi.org/10.1182/blood.V124.21.4245.4245

Published: 2014

Journal Articles

Impact of Transition to Generic Imatinib in the Molecular Response Among Patients with Chronic Myeloid Leukemia

Matthew Kang, BHSc, MD FRCPC, Anargyros Xenocostas, MD FRCPC, Alejandro Lazo-Langner, MD MSc, Ian H. Chin-Yee, MD FRCPC, Kang Howson-Jan, MD, Maisam Abouzeenni, BHSc, Michael J. Kovacs, MD FRCPC, Cyrus C. Hsia, BSc, MD FRCPC

Blood (2014) 124 (21): 5527.

https://doi.org/10.1182/blood.V124.21.5527.5527

Published: 2014

Journal Articles

Detection of Paroxysmal Nocturnal Hemoglobinuria Clones in Patients with Idiopathic Venous Thromboembolism

Alejandro Lazo-Langner, MD MSc, Michael J. Kovacs, MD, Ben Hedley, PhD, Fatimah Al-Ani, MD, Michael Keeney, ART, FIMLS, FCSMLS(D), Martha L Louzada, BSc, MD MSc, Ian H. Chin-Yee, MD FRCPC

Blood (2014) 124 (21): 1532.

https://doi.org/10.1182/blood.V124.21.1532.1532

Published: 2014

NARROW

Double Blind Randomized Control Trial of Postoperative Low Molecular Weight Heparin Bridging Therapy for Patients Who Are at High Risk for Arterial Thromboembolism (PERIOP 2)

Long-Term Risk Factors for Occult Cancer Detection in Patients with Unprovoked Venous Thromboembolism: A Post-Hoc Analysis of the Reverse Study

A Randomized, Open-Label, Blinded Outcome Assessment Trial Evaluating the Efficacy and Safety of LMWH/Edoxaban Versus Dalteparin for Venous Thromboembolism Associated with Cancer: Hokusai VTE-Cancer Study

Post-Thrombotic Syndrome and Functional Disability in Patients with Upper Extremity Deep Vein Thrombosis: A Prospective Cohort Study

Do Genetic Contributors to Warfarin Responsiveness or Common Thrombophilias Influence the Risk of Major Bleeding in Patients on Extended Duration Vitamin K Antagonist (VKA) for Venous Thromboembolic Disease?

Long Term Monitoring of Patients with Positive Lupus Anticoagulant and Antiphospholipid Antibodies. Are All Cases Persistently Positive?

Prediction of Bleeding Risk in Patients on Extended Oral Anticoagulation for Venous Thromboembolism

Lupus Anticoagulant Testing in Patients Receiving Rivaroxaban or Apixaban for the Treatment of Venous Thromboembolism

A Pilot Study in Cancer Patients with Central Venous Catheter Associated Deep Vein Thrombosis in Upper Extremity Treated with Rivaroxaban (Catheter 2)

Safety of Weight-Adjusted Dosing of LMWH in Clinically Obese Cancer Patients with Venous Thromboembolism

Evaluating the Need for Anticoagulation Beyond 6 Months for Patients with Cancer-Associated Venous Thromboembolism (VTE): A Retrospect of Real Life (EXTEND study - updated results)

Management of T-Cell Large Granular Lymphocyte Leukemia with Methotrexate or Cyclophosphamide

Updates on the Risk of Dalteparin Thromboprophylaxis Failure in Hospitalized Acutely Ill Medical Patients with Cancer (ARTIC STUDY)

Brain Natriuretic Peptide, Troponin and D-Dimer Levels in Relation to Long-Term Functional Outcome after a First Episode of Pulmonary Embolism: Results from the E.L.O.P.E. Study

"Post-Pulmonary Embolism Syndrome" after a First Episode of PE: Results of the E.L.O.P.E. Study

A Prospective Cohort Study of Upper Extremity Deep Vein Thrombosis

Dyspnea, Quality of Life and Walking Capacity during 1 Year Follow-up after a First Episode of Pulmonary Embolism: Results of the E.L.O.P.E. Study

Evaluating the Need for Anticoagulation Beyond 6 Months for Patients with Cancer-Associated Venous Thromboembolism: A Retrospect of Real Life (EXTEND Study)

Impact of Transition to Generic Imatinib in the Molecular Response Among Patients with Chronic Myeloid Leukemia

Detection of Paroxysmal Nocturnal Hemoglobinuria Clones in Patients with Idiopathic Venous Thromboembolism

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only